VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+10.73%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$188M
AUM Growth
+$30.7M
(+19%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
10.59%
Top 10 Holdings %
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73
Top Buys
| 1 |
Palantir
PLTR
|
$1.01M |
| 2 |
BlackRock TCP Capital
TCPC
|
$1M |
| 3 |
Host Hotels & Resorts
HST
|
$993K |
| 4 |
DFS
Discover Financial Services
DFS
|
$989K |
| 5 |
Public Storage
PSA
|
$931K |
Top Sells
| 1 |
Burlington
BURL
|
$962K |
| 2 |
Prologis
PLD
|
$773K |
| 3 |
Booking.com
BKNG
|
$734K |
| 4 |
Eaton
ETN
|
$720K |
| 5 |
TE Connectivity
TEL
|
$708K |
Sector Composition
| 1 | Healthcare | 21.52% |
| 2 | Financials | 20.16% |
| 3 | Technology | 16.46% |
| 4 | Industrials | 8.76% |
| 5 | Energy | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
BioCryst Pharmaceuticals
BCRX
$1.74B
| $301K | 0.16% |
59,257
+8,526
| +17% | +$43.3K |
|
227
Ironwood Pharmaceuticals
IRWD
$188M
| $290K | 0.15% |
33,277
+4,788
| +17% | +$41.7K |
|
228
Mirum Pharmaceuticals
MIRM
$3.82B
| $277K | 0.15% |
11,015
+1,585
| +17% | +$39.8K |
|
229
Avidity Biosciences
RNA
$6.48B
| $275K | 0.15% |
10,789
-740
| -6% | -$18.9K |
|
230
Vera Therapeutics
VERA
$1.54B
| $254K | 0.13% |
5,886
-403
| -6% | -$17.4K |
|
231
Acadia Pharmaceuticals
ACAD
$4.26B
| $251K | 0.13% |
13,579
+1,954
| +17% | +$36.1K |
|
232
Apogee Therapeutics
APGE
$2.26B
| $248K | 0.13% |
3,727
-257
| -6% | -$17.1K |
|
233
Western Midstream Partners
WES
$14.5B
| $228K | 0.12% |
+6,421
| New | +$228K |
|
234
Southern Copper
SCCO
$83.6B
| $228K | 0.12% |
2,248
-558
| -20% | -$56.6K |
|
235
Spyre Therapeutics
SYRE
$1.03B
| $221K | 0.12% |
5,838
-401
| -6% | -$15.2K |
|
236
Imperial Oil
IMO
$44.4B
| $221K | 0.12% |
+3,190
| New | +$221K |
|
237
Outfront Media
OUT
$3.05B
| $217K | 0.12% |
+13,158
| New | +$217K |
|
238
Sana Biotechnology
SANA
$752M
| $217K | 0.12% |
21,714
-1,489
| -6% | -$14.9K |
|
239
Viper Energy
VNOM
$6.29B
| $217K | 0.12% |
5,630
-1,614
| -22% | -$62.1K |
|
240
Ovintiv
OVV
$10.6B
| $214K | 0.11% |
+4,118
| New | +$214K |
|
|
VRN
241
DELISTED
Veren
VRN
| $214K | 0.11% |
26,090
+498
| +2% | +$4.08K |
|
242
Canadian Natural Resources
CNQ
$63.2B
| $213K | 0.11% |
+5,588
| New | +$213K |
|
243
Aurinia Pharmaceuticals
AUPH
$1.63B
| $211K | 0.11% |
42,195
+6,071
| +17% | +$30.4K |
|
244
Dyne Therapeutics
DYN
$2.02B
| $208K | 0.11% |
7,326
-507
| -6% | -$14.4K |
|
245
Plains All American Pipeline
PAA
$12.1B
| $208K | 0.11% |
+11,832
| New | +$208K |
|
246
Hess Midstream
HESM
$5.34B
| $206K | 0.11% |
5,712
-1,115
| -16% | -$40.3K |
|
247
Berry Corp
BRY
$249M
| $206K | 0.11% |
+25,600
| New | +$206K |
|
248
Plains GP Holdings
PAGP
$3.64B
| $205K | 0.11% |
+11,260
| New | +$205K |
|
249
Tenaris
TS
$18.2B
| $202K | 0.11% |
+5,153
| New | +$202K |
|
250
Zai Lab
ZLAB
$3.42B
| $202K | 0.11% |
12,613
+1,815
| +17% | +$29.1K |
|